Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseHistocompatibilityBone MarrowBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationTransplantation ConditioningLeukemiaAnemia, AplasticSurvival AnalysisTransplantation, AutologousRadiation ChimeraHematopoietic Stem Cell TransplantationLeukocyte TransfusionGraft RejectionHematopoietic Stem CellsHLA AntigensBone and BonesLymphocyte DepletionMice, Inbred C57BLHost vs Graft ReactionRecurrenceImmunosuppressive AgentsTransplantation, IsogeneicLiver TransplantationGraft Enhancement, ImmunologicLiving DonorsTransplantation ToleranceTreatment OutcomeImmunosuppressionKidney TransplantationBone Marrow PurgingBlood DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesBone Marrow DiseasesBusulfanTime FactorsSkin TransplantationTransplantation ImmunologyGraft vs Host ReactionChimerismTissue and Organ ProcurementAcute DiseaseBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideHematopoiesisHeart TransplantationActuarial AnalysisHematologic NeoplasmsBone Marrow NeoplasmsCombined Modality TherapyLeukemia, Myeloid, AcuteRemission InductionChimeraLymphocyte Culture Test, MixedDisease-Free SurvivalRetrospective StudiesMice, Inbred BALB CLeukemia, MyeloidHepatic Veno-Occlusive DiseaseColony-Forming Units AssayBone RemodelingStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionCord Blood Stem Cell TransplantationMyelodysplastic SyndromesSevere Combined ImmunodeficiencySurvival RateCell DifferentiationFlow CytometryHematologic DiseasesLung TransplantationCyclosporineMice, Inbred C3HSpleenPancytopeniaImmune ToleranceBone DensityOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedLeukocyte CountGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectFollow-Up StudiesCarmustineCytomegalovirus InfectionsCytarabineMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34